Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative… Editor's PickInvesting
Radiopharm Theranostics Receives FDA IND Approval for Phase 2b Imaging Trial in Brain Metastases
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative…
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’), is pleased to announce a non-binding…
Forward Water Technologies Corp. (TSXV: FWTC) (‘ FWTC ‘) and Fraser Mackenzie Accelerator Corp. (TSXV:…
The American stock market rebounded on Monday (July 22) following significant downturns last week, and…
Spartan Resources Limited (“Spartan” or the “Company”) (ASX: Spartan) is pleased to announce the Updated…
Freegold Ventures Limited (TSX: FVL) (OCTQX: FGOVF) (‘Freegold’ or the ‘Company’) is pleased to report…
Markets reacted to the attempted assassination of Former US President Donald Trump, with analysts predicting…
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 15.98 points last week to close at 580.09….
CleanTech Lithium PLC (AIM:CTL, Frankfurt:T2N, OTCQX:CTLHF), an exploration and development company advancing sustainable lithium projects…
The gold price remains historically high, but for Rich Checkan, president and CEO of Asset…